🇺🇸 FDA
Pipeline program

Cyclosporine A

UCB&MSCs-BMF-2023

Phase 2 small_molecule active

Quick answer

Cyclosporine A for Bone Marrow Failure Disorders is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Bone Marrow Failure Disorders
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials